000 05401cam a2200829Ia 4500
001 ocn745970855
003 OCoLC
005 20230823095439.0
006 m o d
007 cr |n|||||||||
008 101020s2011 njua ob 001 0 eng d
040 _aCDX
_beng
_epn
_cCDX
_dIDEBK
_dDG1
_dE7B
_dYDXCP
_dN$T
_dOCLCQ
_dMYG
_dOCLCQ
_dOCLCA
_dOCLCF
_dOCLCQ
_dNLGGC
_dOCLCQ
_dDEBSZ
_dMHW
_dUKDOC
_dDEBBG
_dOCLCQ
_dN$T
_dOCLCQ
019 _a743204852
_a746324257
_a747412618
_a747427281
_a791305549
_a811493653
_a816850646
020 _a9781118023679
_q(electronic bk.)
020 _a1118023676
_q(electronic bk.)
020 _a9781118023655
_q(electronic bk.)
020 _a111802365X
_q(electronic bk.)
020 _a9781118023662
_q(electronic bk.)
020 _a1118023668
_q(electronic bk.)
020 _z9780470616178
_q(Cloth)
020 _z0470616172
_q(Cloth)
020 _z1283175665
020 _z9781283175661
024 8 _a9786613175663
029 1 _aAU@
_b000049641635
029 1 _aDEBBG
_bBV041911509
029 1 _aDEBSZ
_b430989806
029 1 _aDEBSZ
_b449240444
029 1 _aNZ1
_b14693210
029 1 _aSE4M6
_b120058359
029 1 _aDEBBG
_bBV043393342
035 _a(OCoLC)745970855
_z(OCoLC)743204852
_z(OCoLC)746324257
_z(OCoLC)747412618
_z(OCoLC)747427281
_z(OCoLC)791305549
_z(OCoLC)811493653
_z(OCoLC)816850646
037 _a317566
_bMIL
050 4 _aHD9665.5
_b.D38 2011eb
060 4 _aQV 773
072 7 _aMED
_x023000
_2bisacsh
072 7 _aMED
_x058170
_2bisacsh
072 7 _aMED
_x071000
_2bisacsh
072 7 _aMED
_x072000
_2bisacsh
082 0 4 _a615.1068/4
_222
049 _aMAIN
100 1 _aDavison, Mark,
_d1968 March 1-
245 1 0 _aPharmaceutical anti-counterfeiting :
_bcombating the real danger from fake drugs /
_cMark Davison.
260 _aHoboken, N.J. :
_bJohn Wiley & Sons,
_c©2011.
300 _a1 online resource (xxiii, 402 pages) :
_billustrations
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
504 _aIncludes bibliographical references and index.
505 0 _aFrontmatter -- General Themes. Introduction -- Origins and Context of Counterfeiting in Healthcare -- A Snapshot of the Problem -- Risks and Costs of Counterfeit Pharmaceuticals -- Anti-Counterfeiting Definitions -- Protecting and Educating Consumers -- Business Risks and Strategy -- Government Issues -- Intellectual Property and Anti-Counterfeiting -- Traceability or Authentication? -- Authentication. What is Authentication? -- Authentication of the Person -- Authentication of Bulk Products -- On-Dose and In-Dose Authentication -- Analytical Detection of Counterfeit Dosage Forms -- The Role of Packaging -- Printing Technologies -- Security Labels -- Holograms and DOVIDs -- Specialty Inks -- Covert Taggants and Forensic Markers -- General Conclusions on Printed Packaging and Security Labels -- Security of Primary Packaging -- Security of Secondary Packaging -- Analytical Methods for Packaging -- Security of Other Packaging Types -- Bulk Packaging and Transport Security -- Product Tracking. Rationale for Pharmaceutical Tracking -- Tracking Technologies -- Data Format, Generation, and Storage -- Management of Packaging Hierarchy -- Geographical Perspectives -- Product Tracking in Other Industries -- Supply Chain Security Processes -- Implementing Anti-Counterfeiting Initiatives-Practical Issues -- Conclusions and the Future. Where do we go from here? -- New Models, New Approaches -- Selected Examples from around the World -- Further Resources. A Patient's Guide to Avoiding Counterfeit Drugs -- Notes and References -- Glossary -- Further Resources. Information Sources -- Drug Regulators.
520 _aThis book overviews and integrates the business and technical issues that pharmaceutical companies need to know in order to combat the major global problem of counterfeit medicines. In addition to discussion of the problems, the author Davison addresses analytical techniques scientists use to detect counterfeits and presents some possible solutions to the threat of counterfeit medical products. Coverage moves from basic overview of the problem, costs / risks to consumers (toxic products, mistrust of drug companies) and business (revenue loss, public trust), government oversight and regulation, authentication strategies (packaging, analytical techniques), product tracking and supply chain, and case studies from around the globe.
588 0 _aPrint version record.
650 0 _aProduct counterfeiting.
650 0 _aDrug adulteration.
650 2 _aDrug Contamination.
650 2 _aConsumer Product Safety.
650 2 _aFraud
_xprevention & control.
650 2 _aPharmaceutical Preparations
_xstandards.
650 4 _aDrug adulteration.
650 4 _aProduct counterfeiting.
650 7 _aMEDICAL
_xDrug Guides.
_2bisacsh
650 7 _aMEDICAL
_xNursing
_xPharmacology.
_2bisacsh
650 7 _aMEDICAL
_xPharmacology.
_2bisacsh
650 7 _aMEDICAL
_xPharmacy.
_2bisacsh
650 7 _aDrug adulteration.
_2fast
_0(OCoLC)fst00898652
650 7 _aProduct counterfeiting.
_2fast
_0(OCoLC)fst01078205
655 4 _aElectronic books.
776 0 8 _iPrint version:
_z9786613175663
_w(DLC) 2010044590
_w(OCoLC)671465412
856 4 0 _uhttp://dx.doi.org/10.1002/9781118023679
_zWiley Online Library
994 _a92
_bDG1
999 _c18844
_d18803
526 _bgsg